Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic Leukemia

Clinical trial NCT01271283 · WITHDRAWN

Trial details

NCT number: NCT01271283
Sponsor: National Cancer Institute (NCI)
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia

Start date: 2010-12-01
Primary completion: 2011-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.